Risk  ||| S:0 E:5 ||| NN
evaluation  ||| S:5 E:16 ||| NN
and  ||| S:16 E:20 ||| CC
mitigation  ||| S:20 E:31 ||| JJ
strategies ||| S:31 E:41 ||| NNS
:  ||| S:41 E:43 ||| :
impact  ||| S:43 E:50 ||| NN
on  ||| S:50 E:53 ||| IN
patients ||| S:53 E:61 ||| NNS
,  ||| S:61 E:63 ||| ,
health  ||| S:63 E:70 ||| NN
care  ||| S:70 E:75 ||| NN
providers ||| S:75 E:84 ||| NNS
,  ||| S:84 E:86 ||| ,
and  ||| S:86 E:90 ||| CC
health  ||| S:90 E:97 ||| NN
systems  ||| S:97 E:105 ||| NNS
To  ||| S:105 E:108 ||| TO
describe  ||| S:108 E:117 ||| VB
the  ||| S:117 E:121 ||| DT
impetus  ||| S:121 E:129 ||| NN
for  ||| S:129 E:133 ||| IN
and  ||| S:133 E:137 ||| CC
evolution ||| S:137 E:146 ||| NN
,  ||| S:146 E:148 ||| ,
components ||| S:148 E:158 ||| NNS
,  ||| S:158 E:160 ||| ,
and  ||| S:160 E:164 ||| CC
potential  ||| S:164 E:174 ||| JJ
impact  ||| S:174 E:181 ||| NN
on  ||| S:181 E:184 ||| IN
patients ||| S:184 E:192 ||| NNS
,  ||| S:192 E:194 ||| ,
health  ||| S:194 E:201 ||| NN
care  ||| S:201 E:206 ||| NN
providers ||| S:206 E:215 ||| NNS
,  ||| S:215 E:217 ||| ,
and  ||| S:217 E:221 ||| CC
health  ||| S:221 E:228 ||| NN
systems  ||| S:228 E:236 ||| NNS
of  ||| S:236 E:239 ||| IN
risk  ||| S:239 E:244 ||| NN
evaluation  ||| S:244 E:255 ||| NN
and  ||| S:255 E:259 ||| CC
mitigation  ||| S:259 E:270 ||| JJ
strategies  ||| S:270 E:281 ||| NNS
( ||| S:281 E:282 ||| -LRB-
REMS ||| S:282 E:286 ||| NNP
)  ||| S:286 E:288 ||| -RRB-
required  ||| S:288 E:297 ||| VBN
by  ||| S:297 E:300 ||| IN
the  ||| S:300 E:304 ||| DT
Food  ||| S:304 E:309 ||| NNP
and  ||| S:309 E:313 ||| CC
Drug  ||| S:313 E:318 ||| NNP
Administration  ||| S:318 E:333 ||| NNP
( ||| S:333 E:334 ||| -LRB-
FDA ||| S:334 E:337 ||| NNP
)  ||| S:337 E:339 ||| -RRB-
for  ||| S:339 E:343 ||| IN
managing  ||| S:343 E:352 ||| VBG
known  ||| S:352 E:358 ||| VBN
or  ||| S:358 E:361 ||| CC
potential  ||| S:361 E:371 ||| JJ
serious  ||| S:371 E:379 ||| JJ
drug  ||| S:379 E:384 ||| NN
risks ||| S:384 E:389 ||| NNS
.  ||| S:389 E:391 ||| .
A  ||| S:391 E:393 ||| DT
2006  ||| S:393 E:398 ||| CD
report  ||| S:398 E:405 ||| NN
from  ||| S:405 E:410 ||| IN
the  ||| S:410 E:414 ||| DT
Institute  ||| S:414 E:424 ||| NNP
of  ||| S:424 E:427 ||| IN
Medicine  ||| S:427 E:436 ||| NNP
criticizing  ||| S:436 E:448 ||| VBD
FDA  ||| S:448 E:452 ||| NNP
for  ||| S:452 E:456 ||| IN
drug  ||| S:456 E:461 ||| NN
withdrawals  ||| S:461 E:473 ||| NNS
due  ||| S:473 E:477 ||| JJ
to  ||| S:477 E:480 ||| TO
safety  ||| S:480 E:487 ||| NN
problems  ||| S:487 E:496 ||| NNS
provided  ||| S:496 E:505 ||| VBD
the  ||| S:505 E:509 ||| DT
impetus  ||| S:509 E:517 ||| NN
for  ||| S:517 E:521 ||| IN
FDA  ||| S:521 E:525 ||| NNP
to  ||| S:525 E:528 ||| TO
enhance  ||| S:528 E:536 ||| VB
postmarketing  ||| S:536 E:550 ||| JJ
surveillance  ||| S:550 E:563 ||| NN
and  ||| S:563 E:567 ||| CC
to  ||| S:567 E:570 ||| TO
require  ||| S:570 E:578 ||| VB
REMS  ||| S:578 E:583 ||| NNP
for  ||| S:583 E:587 ||| IN
medications  ||| S:587 E:599 ||| NN
with  ||| S:599 E:604 ||| IN
actual  ||| S:604 E:611 ||| JJ
or  ||| S:611 E:614 ||| CC
potential  ||| S:614 E:624 ||| JJ
safety  ||| S:624 E:631 ||| NN
concerns ||| S:631 E:639 ||| NNS
.  ||| S:639 E:641 ||| .
Components  ||| S:641 E:652 ||| NNS
of  ||| S:652 E:655 ||| IN
REMS  ||| S:655 E:660 ||| NNP
may  ||| S:660 E:664 ||| MD
include  ||| S:664 E:672 ||| VB
medication  ||| S:672 E:683 ||| JJ
guides ||| S:683 E:689 ||| NNS
,  ||| S:689 E:691 ||| ,
patient  ||| S:691 E:699 ||| JJ
package  ||| S:699 E:707 ||| NN
inserts ||| S:707 E:714 ||| NNS
,  ||| S:714 E:716 ||| ,
communication  ||| S:716 E:730 ||| NN
plans  ||| S:730 E:736 ||| NNS
for  ||| S:736 E:740 ||| IN
health  ||| S:740 E:747 ||| NN
care  ||| S:747 E:752 ||| NN
providers ||| S:752 E:761 ||| NNS
,  ||| S:761 E:763 ||| ,
and  ||| S:763 E:767 ||| CC
elements  ||| S:767 E:776 ||| NNS
to  ||| S:776 E:779 ||| TO
ensure  ||| S:779 E:786 ||| VB
safe  ||| S:786 E:791 ||| JJ
use  ||| S:791 E:795 ||| NN
( ||| S:795 E:796 ||| -LRB-
e.g. ||| S:796 E:800 ||| NNP
,  ||| S:800 E:802 ||| ,
special  ||| S:802 E:810 ||| JJ
training  ||| S:810 E:819 ||| NN
or  ||| S:819 E:822 ||| CC
certification  ||| S:822 E:836 ||| NN
for  ||| S:836 E:840 ||| IN
prescribing  ||| S:840 E:852 ||| NN
or  ||| S:852 E:855 ||| CC
dispensing ||| S:855 E:865 ||| NN
,  ||| S:865 E:867 ||| ,
dispensing  ||| S:867 E:878 ||| VBG
only  ||| S:878 E:883 ||| RB
under  ||| S:883 E:889 ||| IN
certain  ||| S:889 E:897 ||| JJ
circumstances ||| S:897 E:910 ||| NNS
,  ||| S:910 E:912 ||| ,
special  ||| S:912 E:920 ||| JJ
monitoring ||| S:920 E:930 ||| NN
,  ||| S:930 E:932 ||| ,
use  ||| S:932 E:936 ||| NN
of  ||| S:936 E:939 ||| IN
patient  ||| S:939 E:947 ||| JJ
registries ||| S:947 E:957 ||| NN
) ||| S:957 E:958 ||| -RRB-
.  ||| S:958 E:960 ||| .
Recent  ||| S:960 E:967 ||| JJ
increases  ||| S:967 E:977 ||| NNS
in  ||| S:977 E:980 ||| IN
the  ||| S:980 E:984 ||| DT
number  ||| S:984 E:991 ||| NN
of  ||| S:991 E:994 ||| IN
drugs  ||| S:994 E:1000 ||| NNS
with  ||| S:1000 E:1005 ||| IN
REMS  ||| S:1005 E:1010 ||| NNP
requirements ||| S:1010 E:1022 ||| NNS
,  ||| S:1022 E:1024 ||| ,
MedWatch  ||| S:1024 E:1033 ||| JJ
alerts ||| S:1033 E:1039 ||| NN
,  ||| S:1039 E:1041 ||| ,
and  ||| S:1041 E:1045 ||| CC
the  ||| S:1045 E:1049 ||| DT
development  ||| S:1049 E:1061 ||| NN
of  ||| S:1061 E:1064 ||| IN
the  ||| S:1064 E:1068 ||| DT
new  ||| S:1068 E:1072 ||| JJ
Sentinel  ||| S:1072 E:1081 ||| NNP
Initiative  ||| S:1081 E:1092 ||| NNP
reflect  ||| S:1092 E:1100 ||| VBP
FDA ||| S:1100 E:1103 ||| NNP
's  ||| S:1103 E:1106 ||| POS
commitment  ||| S:1106 E:1117 ||| NN
to  ||| S:1117 E:1120 ||| TO
drug  ||| S:1120 E:1125 ||| NN
safety ||| S:1125 E:1131 ||| NN
.  ||| S:1131 E:1133 ||| .
Patients  ||| S:1133 E:1142 ||| NNS
may  ||| S:1142 E:1146 ||| MD
be  ||| S:1146 E:1149 ||| VB
overwhelmed  ||| S:1149 E:1161 ||| VBN
by  ||| S:1161 E:1164 ||| IN
information  ||| S:1164 E:1176 ||| NN
about  ||| S:1176 E:1182 ||| IN
drugs  ||| S:1182 E:1188 ||| NNS
with  ||| S:1188 E:1193 ||| IN
REMS  ||| S:1193 E:1198 ||| NNP
requirements ||| S:1198 E:1210 ||| NNS
,  ||| S:1210 E:1212 ||| ,
which  ||| S:1212 E:1218 ||| WDT
could  ||| S:1218 E:1224 ||| MD
deter  ||| S:1224 E:1230 ||| VB
the  ||| S:1230 E:1234 ||| DT
use  ||| S:1234 E:1238 ||| NN
of  ||| S:1238 E:1241 ||| IN
potentially  ||| S:1241 E:1253 ||| RB
beneficial  ||| S:1253 E:1264 ||| JJ
therapies ||| S:1264 E:1273 ||| NNS
.  ||| S:1273 E:1275 ||| .
Pharmacists  ||| S:1275 E:1287 ||| NNP
can  ||| S:1287 E:1291 ||| MD
help  ||| S:1291 E:1296 ||| VB
patients  ||| S:1296 E:1305 ||| NNS
weigh  ||| S:1305 E:1311 ||| VBP
the  ||| S:1311 E:1315 ||| DT
risks  ||| S:1315 E:1321 ||| NNS
and  ||| S:1321 E:1325 ||| CC
benefits  ||| S:1325 E:1334 ||| NNS
of  ||| S:1334 E:1337 ||| IN
drug  ||| S:1337 E:1342 ||| NN
therapy ||| S:1342 E:1349 ||| NN
.  ||| S:1349 E:1351 ||| .
Pharmacists ||| S:1351 E:1362 ||| NNP
,  ||| S:1362 E:1364 ||| ,
other  ||| S:1364 E:1370 ||| JJ
health  ||| S:1370 E:1377 ||| NN
care  ||| S:1377 E:1382 ||| NN
providers ||| S:1382 E:1391 ||| NNS
,  ||| S:1391 E:1393 ||| ,
and  ||| S:1393 E:1397 ||| CC
health  ||| S:1397 E:1404 ||| NN
systems  ||| S:1404 E:1412 ||| NNS
may  ||| S:1412 E:1416 ||| MD
find  ||| S:1416 E:1421 ||| VB
REMS  ||| S:1421 E:1426 ||| JJ
requirements  ||| S:1426 E:1439 ||| NNS
challenging ||| S:1439 E:1450 ||| VBG
,  ||| S:1450 E:1452 ||| ,
but  ||| S:1452 E:1456 ||| CC
FDA  ||| S:1456 E:1460 ||| NNP
is  ||| S:1460 E:1463 ||| VBZ
cognizant  ||| S:1463 E:1473 ||| VBN
of  ||| S:1473 E:1476 ||| IN
the  ||| S:1476 E:1480 ||| DT
need  ||| S:1480 E:1485 ||| NN
to  ||| S:1485 E:1488 ||| TO
balance  ||| S:1488 E:1496 ||| VB
the  ||| S:1496 E:1500 ||| DT
goals  ||| S:1500 E:1506 ||| NNS
of  ||| S:1506 E:1509 ||| IN
ensuring  ||| S:1509 E:1518 ||| VBG
drug  ||| S:1518 E:1523 ||| NN
safety  ||| S:1523 E:1530 ||| NN
and  ||| S:1530 E:1534 ||| CC
providing  ||| S:1534 E:1544 ||| VBG
patient  ||| S:1544 E:1552 ||| JJ
access  ||| S:1552 E:1559 ||| NN
to  ||| S:1559 E:1562 ||| TO
drugs  ||| S:1562 E:1568 ||| NNS
without  ||| S:1568 E:1576 ||| IN
placing  ||| S:1576 E:1584 ||| VBG
an  ||| S:1584 E:1587 ||| DT
undue  ||| S:1587 E:1593 ||| JJ
burden  ||| S:1593 E:1600 ||| NN
on  ||| S:1600 E:1603 ||| IN
the  ||| S:1603 E:1607 ||| DT
health  ||| S:1607 E:1614 ||| NN
system ||| S:1614 E:1620 ||| NN
.  ||| S:1620 E:1622 ||| .
The  ||| S:1622 E:1626 ||| DT
goal  ||| S:1626 E:1631 ||| NN
of  ||| S:1631 E:1634 ||| IN
improving  ||| S:1634 E:1644 ||| VBG
drug  ||| S:1644 E:1649 ||| NN
safety  ||| S:1649 E:1656 ||| NN
is  ||| S:1656 E:1659 ||| VBZ
sought  ||| S:1659 E:1666 ||| VBN
by  ||| S:1666 E:1669 ||| IN
the  ||| S:1669 E:1673 ||| DT
FDA ||| S:1673 E:1676 ||| NNP
,  ||| S:1676 E:1678 ||| ,
patients ||| S:1678 E:1686 ||| NNS
,  ||| S:1686 E:1688 ||| ,
health  ||| S:1688 E:1695 ||| NN
care  ||| S:1695 E:1700 ||| NN
providers ||| S:1700 E:1709 ||| NNS
,  ||| S:1709 E:1711 ||| ,
and  ||| S:1711 E:1715 ||| CC
health  ||| S:1715 E:1722 ||| NN
systems  ||| S:1722 E:1730 ||| NNS
alike ||| S:1730 E:1735 ||| RB
.  ||| S:1735 E:1737 ||| .
Collaboration  ||| S:1737 E:1751 ||| NN
among  ||| S:1751 E:1757 ||| IN
health  ||| S:1757 E:1764 ||| NN
care  ||| S:1764 E:1769 ||| NN
providers  ||| S:1769 E:1779 ||| NNS
may  ||| S:1779 E:1783 ||| MD
provide  ||| S:1783 E:1791 ||| VB
efficiencies  ||| S:1791 E:1804 ||| NNS
in  ||| S:1804 E:1807 ||| IN
meeting  ||| S:1807 E:1815 ||| VBG
FDA  ||| S:1815 E:1819 ||| NNP
REMS  ||| S:1819 E:1824 ||| NNP
requirements ||| S:1824 E:1836 ||| NNS
.  ||| S:1836 E:1838 ||| .
